Touchstone International Medical Science Co., Ltd. (SHA:688013)
27.70
+0.76 (2.82%)
Jun 18, 2026, 3:00 PM CST
SHA:688013 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 81.69 | 85.19 | 51.89 | 47.31 | 43.2 | 41.42 |
Depreciation & Amortization | 12.44 | 12.44 | 10.51 | 9.72 | 8.34 | 7.22 |
Other Amortization | 0.64 | 0.64 | 0.15 | 0.12 | 0.1 | 0.02 |
Loss (Gain) From Sale of Assets | -0.41 | -0.41 | - | -0 | -0.05 | -0.52 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0 | 0 | 0.02 | 0.05 |
Loss (Gain) From Sale of Investments | -11.24 | -11.24 | -4.67 | -9.62 | -6.57 | -10.91 |
Provision & Write-off of Bad Debts | 1.56 | 1.56 | -0.06 | 0.31 | 0.17 | 0.22 |
Other Operating Activities | -21.5 | -9.95 | 0.59 | -2.2 | -3.33 | -4 |
Change in Accounts Receivable | -26.28 | -26.28 | -4.16 | -4.24 | -2.92 | -4.31 |
Change in Inventory | -3.49 | -3.49 | -1.9 | 4.16 | -7.69 | -0.14 |
Change in Accounts Payable | 17.24 | 17.24 | -12.66 | 19.19 | -1.57 | 14.41 |
Change in Other Net Operating Assets | 5.27 | 5.27 | 11.93 | 20 | 20.08 | 20.58 |
Operating Cash Flow | 56.94 | 71.99 | 53.41 | 82.95 | 50.4 | 60.98 |
Operating Cash Flow Growth | -1.40% | 34.78% | -35.61% | 64.57% | -17.34% | 44.90% |
Capital Expenditures | -92.41 | -90.75 | -41.94 | -18.41 | -47.67 | -9.21 |
Sale of Property, Plant & Equipment | 0.48 | 0.48 | - | - | 0.06 | 0.64 |
Investment in Securities | 162.29 | 113.74 | -120.37 | 110.82 | 13.9 | -102.5 |
Other Investing Activities | -1.58 | -5.94 | 15.11 | 5.56 | 4.48 | 10.47 |
Investing Cash Flow | 68.78 | 17.52 | -147.2 | 97.97 | -29.23 | -100.59 |
Short-Term Debt Issued | - | - | - | - | 37.3 | - |
Long-Term Debt Issued | - | 80.39 | 49.72 | - | - | - |
Total Debt Issued | 109.21 | 80.39 | 49.72 | - | 37.3 | - |
Short-Term Debt Repaid | - | - | - | - | -37.3 | - |
Long-Term Debt Repaid | - | -33.11 | -50.73 | -0.71 | -0.36 | - |
Total Debt Repaid | -56.63 | -33.11 | -50.73 | -0.71 | -37.66 | - |
Net Debt Issued (Repaid) | 52.58 | 47.28 | -1.01 | -0.71 | -0.36 | - |
Issuance of Common Stock | 7.97 | 22.72 | 27.16 | 15.77 | 13.98 | - |
Repurchase of Common Stock | -9.12 | -9.12 | -41.5 | - | -65.08 | - |
Common Dividends Paid | -82.52 | -121.58 | -38.31 | -19.8 | -15.94 | -16 |
Other Financing Activities | 0.08 | - | - | - | - | - |
Financing Cash Flow | -31.01 | -60.7 | -53.66 | -4.74 | -67.39 | -16 |
Foreign Exchange Rate Adjustments | 4.03 | 5.84 | 0.05 | 2.3 | 3.86 | 4.25 |
Net Cash Flow | 98.74 | 34.65 | -147.41 | 178.48 | -42.37 | -51.36 |
Free Cash Flow | -35.47 | -18.76 | 11.47 | 64.54 | 2.73 | 51.77 |
Free Cash Flow Growth | - | - | -82.23% | 2263.10% | -94.73% | 48.80% |
Free Cash Flow Margin | -11.21% | -5.74% | 4.21% | 25.44% | 1.18% | 24.22% |
Free Cash Flow Per Share | -0.44 | -0.23 | 0.14 | 0.79 | 0.03 | 0.64 |
Cash Income Tax Paid | 15.34 | 16.26 | 14.46 | 17.84 | 9.94 | 15.35 |
Levered Free Cash Flow | -72.41 | -58.15 | 2.69 | 46.22 | -9.72 | 42.8 |
Unlevered Free Cash Flow | -71.99 | -57.86 | 2.83 | 46.28 | -9.62 | 42.8 |
Change in Working Capital | -6.26 | -6.26 | -5.01 | 37.32 | 8.52 | 27.48 |